Of the 33 participants , 19/21 ( 90 % ) randomized to -3 PUFAs + - LA relapsed and one ( 5 % ) completed two years without relapse ( p = 0.6 ) ; and 9/12 ( 75 % ) randomized to placebo relapsed and none completed two years without relapse .